Prospective Molecular Characterization of Multiple Myeloma Patient Samples Identifies High-Risk Patients and Informs Treatment Sequences through Resistance Mechanisms to ImmunotherapiesPhillip Pham, Brian A. Walker, Cameron Morgan et al.|Blood|2023Cited by 5
Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selectionParvathi Sudha, Brian A. Walker, Phillip Pham et al.|Blood Advances|2025Cited by 0